Clinical trials
Completed Inflammation trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
923 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2003 | 6 |
| 2004 | 12 |
| 2005 | 15 |
| 2006 | 19 |
| 2007 | 20 |
| 2008 | 24 |
| 2009 | 42 |
| 2010 | 39 |
| 2011 | 50 |
| 2012 | 49 |
| 2013 | 45 |
| 2014 | 41 |
| 2015 | 51 |
| 2016 | 58 |
| 2017 | 51 |
| 2018 | 48 |
| 2019 | 65 |
| 2020 | 39 |
| 2021 | 56 |
| 2022 | 61 |
| 2023 | 52 |
| 2024 | 42 |
| 2025 | 27 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 923 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Appalachian State University | 19 |
| University of Sao Paulo | 10 |
| University of Florida | 9 |
| Emory University | 8 |
| Loma Linda University | 8 |
| Maastricht University Medical Center | 8 |
| University of California, Los Angeles | 8 |
| Radboud University Medical Center | 7 |
| University of Aarhus | 7 |
| University of British Columbia | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 923 |
| Obesity | 118 |
| Insulin Resistance | 66 |
| Cardiovascular Diseases | 55 |
| Metabolic Syndrome | 52 |
| Diabetes Mellitus, Type 2 | 38 |
| Overweight | 34 |
| Diabetes Mellitus | 21 |
| Pain | 19 |
| Dyslipidemias | 17 |
Trials
Showing 1 to 25 of 923. Each trial links to its page on Pharma Observatory.
823 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.